Calnexin (CANX) complexes on the cell surface can reduce the number of extracellular disulfide bonds, thereby degrading the extracellular matrix, which serves as a physical barrier to HCC growth, thereby inducing tumor growth and invasion (35). Here, CANX is linked to hepatocellular carcinoma.